Medicare Medicaid Category

Medicare & Medicaid

News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.

Medicare Advantage’s Growth Spurt Brings Tensions

If trends hold, more people will choose a Medicare Advantage plan over traditional Medicare during the open enrollment season that began Sunday. That’s amping up concern about the way plans are marketed, how the government pays insurers who administer benefits and the way they’ve turned down millions of requests for coverage of services and drugs. The big ...

Read More

Drugmakers Sign On To Negotiate Medicare Prices Under Protest

All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health program, including Amgen (AMGN.O) and Novartis (NOVN.S), said they signed on to participate in the talks by the Oct. 1 deadline.

Read More

Senators Debate Ways To Ensure Medicare’s Solvency

Democratic members of the Senate Budget Committee voiced support for taxing the wealthy and increasing Medicare spending, arguing Republicans want to keep the status quo for corporations enjoying favorable tax breaks, during a hearing Thursday. The Medicare Fund could become insolvent as early as 2031, according to analysis by the boards of trustees of the Social Security ...

Read More

Medicare Enrollment Begins In 2 Weeks. Here’s What Major Payers Are Offering For 2024

The industry is just two weeks away from the beginning of Medicare’s annual enrollment period, a critical window for the hottest market in insurance. The period begins Oct. 15 and runs through Dec. 7, and Medicare beneficiaries will be tasked with the critical decision of enrolling in the fee-for-service program or opting instead for Medicare ...

Read More

Federal Court Hears First Oral Arguments In Legal Battle Over Medicare Negotiation

The Southern District Court of Ohio on Friday heard oral arguments from the federal government and the Chamber of Commerce in the latter’s lawsuit challenging the Medicare Drug Price Negotiation Program, with both sides rehashing long-held assertions. The Chamber has requested that the Medicare negotiation program be blocked from operating, with the organization asking for ...

Read More

Low-Income Seniors Report Deceptive Medicare Marketing: Study

Seniors are becoming increasingly overburdened by marketing efforts from private Medicare plans, and low-income beneficiaries are twice as likely to file complaints regarding fraudulent phone calls compared to high-income counterparts, according to a study from The Commonwealth Fund. The study found that 22% of low-income adults report receiving fraudulent calls, while just 10% of higher-income individuals report ...

Read More

Beneficiaries Switching From Traditional Medicare Helped Fuel Huge Growth In MA

Much of the growth experienced by Medicare Advantage over the last two decades can be attributed to beneficiaries switching from traditional Medicare to MA, a trend that’s accelerated in recent years, according to a study published today in Health Affairs. “We found that switching from fee-for-service Medicare into MA, particularly by younger and healthier beneficiaries, has driven the increased ...

Read More

Biden Administration Expects To Win Fight Over Medicare Drug Negotiations

White House domestic policy adviser Neera Tanden said Sunday that she’s convinced that the Inflation Reduction Act’s Medicare drug price negotiation program will be upheld in court. Speaking on “The Katie Phang Show” on MSNBC, Tanden said, “There is nothing in the Constitution that stops Medicare from negotiating drug prices. We really, we feel very ...

Read More

Humana Sues Feds Over Medicare Advantage Risk Adjustment Changes

Humana has filed suit against the feds, saying the Biden administration’s bid to claw back overpayments in Medicare Advantage (MA) is built on “shifting justifications and erroneous legal reasoning.” Earlier this year, the Centers for Medicare & Medicaid Services (CMS) finalized a hotly anticipated rule that would overhaul risk adjustment data validation (RADV) audits, which determine whether ...

Read More

Biden Administration Unveils First 10 Drugs Subject To Medicare Price Negotiations

The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square